Octapharma USA Inc

BALFAXAR

Manufacturer:

Octapharma USA Inc

Balfaxar HCPCS:

C9159

HCPCS Code Descriptor:

Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity

Category:

C Code

Balfaxar NDCs:

68982-0261-02, 68982-0261-01

Primary Type:

Anticoagulant

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Balfaxar:

BALFAXAR is an Anticoagulant drug manufactured by Octapharma USA Inc and administered via the Intravenous route of administration. The C Code: C9159 is aligned to the drug BALFAXAR.

ACCESS PRICING AND MORE BY REGISTERING

C9159 Added Date:

January 1, 2024

C9159 Effective Date:

January 1, 2024

C9159 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Balfaxar billing and coding information.
Our team did not identify a source for Balfaxar patient assistance information. Please reach out to our team if you feel that this is a mistake.
BALFAXAR prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BALFAXAR. Please check back in a few weeks.